A detailed history of Bennicas & Associates, Inc. transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Bennicas & Associates, Inc. holds 25,506 shares of BMY stock, worth $1.5 Million. This represents 1.17% of its overall portfolio holdings.

Number of Shares
25,506
Previous 25,506 -0.0%
Holding current value
$1.5 Million
Previous $1.84 Million 0.05%
% of portfolio
1.17%
Previous 1.06%

Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Jan 12, 2023

SELL
$68.48 - $81.09 $23,968 - $28,381
-350 Reduced 1.35%
25,506 $1.84 Million
Q3 2022

Oct 13, 2022

SELL
$0.13 - $76.84 $19 - $11,526
-150 Reduced 0.58%
25,856 $1.84 Million
Q1 2022

Apr 15, 2022

SELL
$61.48 - $73.72 $3,811 - $4,570
-62 Reduced 0.24%
26,006 $1.9 Million
Q4 2021

Jan 14, 2022

SELL
$53.63 - $62.52 $53 - $62
-1 Reduced -0.0%
26,068 $1.63 Million
Q2 2021

Jul 09, 2021

SELL
$61.91 - $67.42 $6,191 - $6,742
-100 Reduced 0.38%
26,069 $1.74 Million
Q1 2021

Apr 15, 2021

SELL
$59.34 - $66.74 $16,259 - $18,286
-274 Reduced 1.04%
26,169 $1.65 Million
Q4 2020

Jan 15, 2021

SELL
$57.74 - $65.43 $8,661 - $9,814
-150 Reduced 0.56%
26,443 $1.64 Million
Q3 2020

Oct 15, 2020

SELL
$57.43 - $63.64 $9,648 - $10,691
-168 Reduced 0.63%
26,593 $1.6 Million
Q2 2020

Jul 14, 2020

SELL
$54.82 - $64.09 $767 - $897
-14 Reduced 0.05%
26,761 $1.57 Million
Q1 2020

Apr 15, 2020

SELL
$46.4 - $67.43 $88,160 - $128,117
-1,900 Reduced 6.63%
26,775 $1.49 Million
Q4 2019

Jan 17, 2020

SELL
$49.21 - $64.19 $14,763 - $19,257
-300 Reduced 1.04%
28,675 $1.84 Million
Q2 2019

Jul 12, 2019

SELL
$44.62 - $49.34 $8,924 - $9,868
-200 Reduced 0.69%
28,975 $1.31 Million
Q4 2018

Jan 18, 2019

SELL
$48.76 - $63.23 $9,752 - $12,646
-200 Reduced 0.68%
29,175 $1.52 Million
Q2 2018

Jul 20, 2018

SELL
$50.53 - $62.98 $10,106 - $12,596
-200 Reduced 0.68%
29,375 $1.63 Million
Q1 2018

Apr 20, 2018

SELL
$59.92 - $68.98 $68,908 - $79,327
-1,150 Reduced 3.74%
29,575 $1.87 Million
Q4 2017

Jan 24, 2018

SELL
$59.94 - $65.35 $119,880 - $130,699
-2,000 Reduced 6.11%
30,725 $1.88 Million
Q3 2017

Oct 25, 2017

BUY
$55.23 - $63.74 $1.81 Million - $2.09 Million
32,725
32,725 $2.09 Million

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $125B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Bennicas & Associates, Inc. Portfolio

Follow Bennicas & Associates, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bennicas & Associates, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Bennicas & Associates, Inc. with notifications on news.